Presented to the HFMA South Texas Chapter
Clinical denial appeals and No Surprises Act (NSA) disputes aren’t as separate as most teams think. In this session, Aspirion’s revenue cycle experts show how the strategies winning one can strengthen the other.
Watch now to learn how to:
- Spot where your denials and NSA/IDR workflows overlap—and turn that overlap into an advantage
- Apply AI-driven strategies improving win rates on both appeals and out-of-network disputes
- Use a simple framework to measure impact and build the case for smarter recovery internally
